<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The multiple <z:hpo ids='HP_0100568'>endocrine neoplasia</z:hpo> syndromes are divided into two categories: MEN type I and <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN type II</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN type II</z:e> syndrome is further divided into <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN IIa</z:e> and <z:e sem="disease" ids="C0025269" disease_type="Neoplastic Process" abbrv="MEN2b">MEN IIb</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The syndromes are characterized by benign and malignant changes in two or more <z:chebi fb="32" ids="24621">endocrine</z:chebi> organs, as well as incidental changes in <z:mp ids='MP_0008912'>nervous</z:mp>, muscular and connective tissue </plain></SENT>
<SENT sid="3" pm="."><plain>Two main forms can be distinguished: the MEN-I syndrome with <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> of the parathyroid gland, accompanied by <z:e sem="disease" ids="C0242363" disease_type="Neoplastic Process" abbrv="">islet cell tumor</z:e> and <z:hpo ids='HP_0002893'>pituitary adenoma</z:hpo>; the <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN-II</z:e> syndrome with <z:hpo ids='HP_0002865'>medullary thyroid carcinoma</z:hpo> in combination with bilateral <z:hpo ids='HP_0002666'>pheochromocytoma</z:hpo> and <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> of the parathyroid gland (<z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN IIa</z:e>), while type IIb is characterized by the additional appearance of neurocutaneous manifestations without <z:hpo ids='HP_0008200'>primary hyperparathyroidism</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Characteristics shared by these syndromes include the involved cell type, most of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are composed of one or more specific <z:chebi fb="1" ids="15841">polypeptide</z:chebi>- and biogenic <z:chebi fb="39" ids="32952">amine</z:chebi>-producing cell types (APUD--<z:chebi fb="39" ids="32952">amine</z:chebi> precursor uptake and decarboxylation) </plain></SENT>
<SENT sid="5" pm="."><plain>The second characteristic is the increased incidence in certain families </plain></SENT>
<SENT sid="6" pm="."><plain>The hereditary component is <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> with variable expression but high penetrance </plain></SENT>
<SENT sid="7" pm="."><plain>Mechanisms of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> differ in these syndromes </plain></SENT>
<SENT sid="8" pm="."><plain>While MEN I is caused by an inherited mutation of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene, menin, located on the long arm of chromosome 11, <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN II</z:e> is caused by activation of the RET proto-oncogene </plain></SENT>
<SENT sid="9" pm="."><plain>We have reported the case of a young man exhibiting bilateral <z:hpo ids='HP_0002666'>pheochromocytoma</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, the patient showed mild <z:hpo ids='HP_0008200'>primary hyperparathyroidism</z:hpo> and <z:hpo ids='HP_0001519'>marfanoid habitus</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> these stigmata usually being part of the <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN-II</z:e> syndrome </plain></SENT>
<SENT sid="11" pm="."><plain>Although this described patient showed a phenotypic mixture of the <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN-IIa</z:e> and <z:e sem="disease" ids="C0025269" disease_type="Neoplastic Process" abbrv="MEN2b">MEN-IIb</z:e> syndrome, the genetic analysis for <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN II</z:e> and von-Hippel-Lindau gene did not reveal any pathologic mutations, the <z:chebi fb="32" ids="24621">endocrine</z:chebi> disorders described here are not related to multiple <z:hpo ids='HP_0100568'>endocrine neoplasia</z:hpo> syndromes </plain></SENT>
</text></document>